ATH 33.3% 0.4¢ alterity therapeutics limited

when is the trial for normal cognition decline

  1. 5,921 Posts.
    lightbulb Created with Sketch. 151
    Now they have not only reversed decline, they have bought the aged forgetful wild type model back to the same level as young mice. Has anybody asked the company if they intend to test that in a separate clinical trial?
    At the end of Dr Adlard's comments he recommended a human trial. As this may be the point that Alzheimer's can be stopped I think it is quite important to get on it right away.
    Rewards will be enormous for Prana with both normal age related cognition decline and Alzheimer's, but Govts have a lot more at stake with a wave of AD cases closing in as the boomers age.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.